Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization.
Near-IR plasmonic nanoparticles kill tumour tissue
ETH researchers have developed plasmonic particles that are relatively easy to produce and have a wide range of applications, including cancer treatment.
Stimulating neurons with IR-responsive gold nanorods
Silica-coated gold nanorods with absorption at precisely 780 nm cause action potentials in nerve cells when exposed to laser light.
Funding to develop anti-heart-disease nanoparticles
A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received £3 million funding.
Fluorescence shows real-time nanoparticle biodegradation
New method allows researchers to directly measure nanoparticle degradation in real time within biological environments.
New hydrogel promotes bone growth on titanium implants
New gel to promote bone growth on implants used in orthopaedic and dental surgical procedures.
Evaluating chemotherapeutic response in breast cancer
The need to develop biocompatible and biodegradable materials has intensified as the fields of bioengineering and regenerative medicine come of age.
Glutathione-sensitive nanoparticles get drugs straight to the source of cancer
Korean scientists have developed a tumor-targeted, bioreducible nanoparticle system that can deliver cytotoxic anticancer drugs to tumor tissues.
Anti-cancer system bursts nanoballoons with lasers
New drug delivery method targets cancer cells – not the entire body – and limits chemotherapy side effects.
Iron carbide nanoparticles: a new platform for tumor theranostics
New core/shell structure nanoparticles have been reported by a team led by Peking University researchers.